LUPIN
Back to Balance Sheet
|
LUPIN Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹12,651 Cr | ₹8,961 Cr | ₹8,502 Cr | ₹9,265 Cr | ₹8,276 Cr |
What is the latest Total Current Liabilities ratio of LUPIN ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹12,651 Cr |
| Mar2025 | ₹8,961 Cr |
| Mar2024 | ₹8,502 Cr |
| Mar2023 | ₹9,265 Cr |
| Mar2022 | ₹8,276 Cr |
How is Total Current Liabilities of LUPIN Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹12,651 Cr | 41.17 | |
| Mar2025 | ₹8,961 Cr | 5.41 | |
| Mar2024 | ₹8,502 Cr | -8.24 | |
| Mar2023 | ₹9,265 Cr | 11.95 | |
| Mar2022 | ₹8,276 Cr | - | |
Compare Total Current Liabilities of peers of LUPIN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LUPIN | ₹112,903.3 Cr | 0.5% | 7.7% | 26.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,507.0 Cr | 2.8% | 7.4% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹190,744.0 Cr | 6.4% | 8.3% | 0.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹168,250.0 Cr | 2.1% | 8.7% | 47.7% | Stock Analytics | |
| CIPLA | ₹116,213.0 Cr | 0.5% | 3.6% | -5.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,980.0 Cr | -7.6% | -2.2% | -5.8% | Stock Analytics | |
LUPIN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LUPIN | 0.5% |
7.7% |
26.3% |
| SENSEX | -1.4% |
4.4% |
-7.6% |
You may also like the below Video Courses